Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Johnson, Kirsten M ^a,b   Taslim, Cenny ^b   Saund, Ranajeet S ^b   Lessnick, Stephen L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EWS FLI PROTEIN; HYBRID PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; EWS-FLI FUSION PROTEIN; MICROSATELLITE DNA; ONCOPROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DNA STRUCTURE; ENHANCER REGION; EWING SARCOMA; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GGAA MICROSATELLITE; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE;

CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSATELLITE REPEATS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-FLI-1; RNA-BINDING PROTEIN EWS; SARCOMA, EWING;

EID: 85032915569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186275     Document Type: Article

References (45)

1. Braun BS, Frieden R, Lessnick SL, May WA, Denny CT. Identification of target genes for the Ewing’s sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol. 1995; 15: 4623–30. PMID: 7623854
2. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol. 1994; 14: 3230–41. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=358690&tool=pmcentrez&rendertype=abstract PMID: 8164678
3. Lamber EP, Vanhille L, Textor LC, Kachalova GS, Sieweke MH, Wilmanns M. Regulation of the transcription factor Ets-1 by DNA-mediated homo-dimerization. EMBO J. 2008; 27: 2006–17. https://doi.org/10.1038/emboj.2008.117 PMID: 18566588
4. Ohno T, Rao VN, Shyam E, Reddy P. EWS/Fli-1 Chimeric Protein Is a Transcriptional Activator. Cancer Res. 1993; 53: 5859–5863. PMID: 7503813
5. Sorensen PH, Triche TJ. Gene fusions encoding chimaeric transcription factors in solid tumours. Semin Cancer Biol. 1996; 7: 3–14. https://doi.org/10.1006/scbi.1996.0002 PMID: 8695764
6. Obika S, Reddy SY, Bruice TC. Sequence specific DNA binding of Ets-1 transcription factor: molecular dynamics study on the Ets domain—DNA complexes. J Mol Biol. 2003; 331: 345–59. PMID: 12888343
7. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB. The FLI-1 and chimeric EWS-FLI-1 oncopro-teins display similar DNA binding specificities. J Biol Chem. 1994; 269: 18216–22. PMID: 7517940
8. Szymczyna BR, Arrowsmith CH. DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition. J Biol Chem. 2000; 275: 28363–70. https://doi.org/10.1074/jbc.M004294200 PMID: 10867009
9. Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, et al. Microsatellites as EWS/FLI response elements in Ewing’s sarcoma. Proc Natl Acad Sci U S A. 2008; 105: 10149–54. https://doi.org/10.1073/pnas.0801073105 PMID: 18626011
10. Richard G-F, Kerrest A, Dujon B. Comparative Genomics and Molecular Dynamics of DNA Repeats in Eukaryotes. Microbiol Mol Biol Rev. 2008; https://doi.org/10.1128/MMBR.00011-08 PMID: 19052325
11. Sawaya S, Bagshaw A, Buschiazzo E, Kumar P, Chowdhury S, Black MA, et al. Microsatellite Tandem Repeats Are Abundant in Human Promoters and Are Associated with Regulatory Elements. PLoS One. 2013; https://doi.org/10.1371/journal.pone.0054710 PMID: 23405090
12. Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O. The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One. Public Library of Science; 2009; 4: e4932. https://doi.org/10.1371/journal.pone.0004932 PMID: 19305498
13. Riggi N, Knoechel B, Gillespie SM, Rheinbay E, Boulay G, Suvà ML, et al. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell. 2014; 26: 668–81. https://doi.org/10.1016/j.ccell.2014.10.004 PMID: 25453903
14. Tomazou EM, Sheffield NC, Schmidl C, Schuster M, Schönegger A, Datlinger P, et al. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. Cell Rep. 2015; 10: 1082–95. https://doi.org/10.1016/j.celrep.2015.01.042 PMID: 25704812
15. Monument MJ, Johnson KM, Grossmann AH, Schiffman JD, Randall RL, Lessnick SL. Microsatellites with macro-influence in ewing sarcoma. Genes (Basel). 2012; 3: 444–60. https://doi.org/10.3390/genes3030444 PMID: 24704979
16. Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Scott Watkins W, Jorde LB, et al. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: A report from the Children’s Oncology Group. PLoS One. Public Library of Science; 2014; 9: e104378. https://doi.org/10.1371/journal.pone.0104378 PMID: 25093581
17. Lessnick SL, Dacwag CS, Golub TR. The Ewing’s sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell. 2002; 1: 393–401. https://doi.org/10.1016/S1535-6108(02)00056-9 PMID: 12086853
18. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing’s family of tumors. Cancer Res. 2005; 65: 4633–4644. https://doi.org/10.1158/0008-5472.CAN-04-2857 PMID: 15930281
19. Pagès H. Biostrings: String objects representing biological sequences, and matching algorithms. R package; 2016.
20. Pagès H. BSgenome: Infrastructure for Biostrings-based genome data packages and support for efficient SNP representation. R package; 2016.
21. Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS, et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics. BioMed Central; 2010; 11: 237. https://doi.org/10.1186/1471-2105-11-237 PMID: 20459804
22. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes & Dev. 2007; 21: 1882–1894. https://doi.org/10.1101/gad.1561707 PMID: 17652178
23. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25: 2078–9. https://doi.org/10.1093/bioinformatics/btp352 PMID: 19505943
24. Feng J, Liu T, Qin B, Zhang Y, Liu XS. Identifying ChIP-seq enrichment using MACS. Nat Protoc. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2012; 7: 1728–40. https://doi.org/10.1038/nprot.2012.101 PMID: 22936215
25. Gel B, Díez-Villanueva A, Serra E, Buschbeck M, Peinado MA, Malinverni R. regioneR: an R/Bioconductor package for the association analysis of genomic regions based on permutation tests. Bioinformatics. 2016; 32: 289–91. https://doi.org/10.1093/bioinformatics/btv562 PMID: 26424858
26. Sankar S, Gomez NC, Bell R, Patel M, Davis IJ, Lessnick SL, et al. EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma. Genes Cancer. 2013; 4: 213–23. https://doi.org/10.1177/1947601913489569 PMID: 24069508
27. Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2014. Nucleic Acids Res. Oxford University Press; 2014; 42: D749–55. https://doi.org/10.1093/nar/gkt1196 PMID: 24316576
28. Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol. Public Library of Science; 2013; 9: e1003118. https://doi.org/10.1371/journal.pcbi.1003118 PMID: 23950696
29. Morgan M, Obenchain V, Lang M, Thompson R. BiocParallel: Bioconductor facilities for parallel evaluation. R package; 2016.
30. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15: 550. https://doi.org/10.1186/s13059-014-0550-8 PMID: 25516281
31. Kolde R. pheatmap: Pretty Heatmaps. R package; 2015.
32. Wickham H. ggplot2: Elegant graphics for data analysis (use R!). New York: Springer; 2009.
33. Cleveland WS. Locally-Weighted Regression: An Approach to Regression Analysis by Local Fitting. J Am Stat Assoc. 1988; 85: 596–610.
34. Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, et al. Solution structure of the ets domain of Fli-1 when bound to DNA. Nat Struct Biol. 1994; 1: 871–875. https://doi.org/10.1038/nsb1294-871 PMID: 7773776
35. Gangwal kunal, lessnick stephen. Microsatellites are EWS / FLI response elements. Cell Cycle. 2008; 7: 3127–3132. https://doi.org/10.4161/cc.7.20.6892 PMID: 18927503
36. Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B, et al. Model-based Analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9: R137+. https://doi.org/10.1186/gb-2008-9-9-r137 PMID: 18798982
37. Gangwal K, Close D, Enriquez CA, Hill CP, Lessnick SL. Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing’s Sarcoma. Genes Cancer. 2010; 1: 177–187. https://doi.org/10.1177/1947601910361495 PMID: 20827386
38. Johnson KM, Mahler NR, Saund RS, Theisen ER, Taslim C, Callender NW, et al. Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth. Proc Natl Acad Sci. 2017; 201701872. https://doi.org/10.1073/pnas.1701872114 PMID: 28847958
39. Slattery M, Zhou T, Yang L, Dantas Machado AC, Gordân R, Rohs R. Absence of a simple code: how transcription factors read the genome. Trends Biochem Sci. 2014; 39: 381–399. https://doi.org/10.1016/j.tibs.2014.07.002 PMID: 25129887
40. Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, et al. Mechanism and relevance of EWS/ FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene. 2013; 32: 5089–100. https://doi.org/10.1038/onc.2012.525 PMID: 23178492
41. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. Elsevier; 2013; 155: 934–47. https://doi.org/10.1016/j.cell.2013.09.053 PMID: 24119843
42. Pott S, Lieb JD. What are super-enhancers? Nat Genet. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2015; 47: 8–12. https://doi.org/10.1038/ng.3167 PMID: 25547603
43. Kennedy AL, Vallurupalli M, Chen L, Crompton B, Cowley G, Vazquez F, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015; 6: 30178–93. https://doi.org/10.18632/oncotarget.4903 PMID: 26337082
44. Boulay G, Sandoval GJ, Riggi N, Iyer S, Buisson R, Naigles B, et al. Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. Cell. 2017; https://doi.org/10.1016/j.cell.2017.07.036 PMID: 28844694
45. Wei G-H, Badis G, Berger MF, Kivioja T, Palin K, Enge M, et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 2010; 29: 2147–60. https://doi.org/10.1038/emboj.2010.106 PMID: 20517297